# PharmExec

> PharmExec - Healthcare Publication

- Base URL: https://www.pharmexec.com
- Generated: 2026-07-06T03:34:59.245Z
- Content updates: multiple times daily

## Content Access for AI Agents

This site supports content negotiation for AI/LLM consumption. Request any article URL with an appropriate Accept header to receive structured content instead of HTML.

**Supported content types:**
- `text/markdown` — Clean Markdown with YAML frontmatter
- `text/plain` — Plain text (same as Markdown)
- `text/html` — Default HTML response

**Example request:**
```
curl -H "Accept: text/markdown" https://www.pharmexec.com/view/article-slug
```

**YAML frontmatter schema** (returned with every Markdown response):

| Field | Type | Description |
|-------|------|-------------|
| `title` | string | Article headline |
| `description` | string | Summary/excerpt (max 300 chars) |
| `url` | string | Canonical article URL |
| `canonical_url` | string | Canonical URL if different from `url` |
| `published` | ISO 8601 | Original publication date |
| `modified` | ISO 8601 | Last modification date |
| `authors` | string[] | Author display names |
| `content_type` | string | Content category (e.g., "News", "Clinical") |
| `categories` | string[] | Taxonomy categories |
| `tags` | string[] | SEO tags |
| `image` | string | Featured image URL |
| `publisher` | string | Publication/site name |

**Discovery headers** (included on all responses):
- `Link: <https://www.pharmexec.com/llms.txt>; rel="llms"` — RFC 8288 link to this file
- `X-Llms-Txt: https://www.pharmexec.com/llms.txt` — Explicit discovery header

## Usage Policy

- Robots policy: [https://www.pharmexec.com/robots.txt](https://www.pharmexec.com/robots.txt)
- Cache behavior: responses are cached for ~5 minutes (max-age=300, stale-while-revalidate=329)
- Rate guidance: prefer RSS and sitemap feeds over crawling individual pages
- Attribution: All content © MJH Life Sciences. Include source URLs when citing.

## Content Categories

- [Content Engagement Hubs](https://www.pharmexec.com/content-engagement-hubs)
- [Country Reports](https://www.pharmexec.com//topic/country-reports)
- [Editorial Podcasts](https://www.pharmexec.com/editorial-podcasts)
- [Editorial Videos](https://www.pharmexec.com/editorial-videos)
- [Events](https://www.pharmexec.com/events)
- [Front & Center](https://www.pharmexec.com/front-center)
- [News](https://www.pharmexec.com/news)
- [Pharma Pulse](https://www.pharmexec.com/pharma-pulse)
- [Profiles in Medicine](https://www.pharmexec.com/profiles-in-medicine)
- [Sponsored Content](https://www.pharmexec.com/sponsored-content)
- [Sponsored Podcasts](https://www.pharmexec.com/sponsored-podcasts)
- [Sponsored Videos](https://www.pharmexec.com/sponsored-videos)
- [Topic](https://www.pharmexec.com/topic)
- [Video Series](https://www.pharmexec.com/video-series)
- [Webcasts](https://www.pharmexec.com/webcasts)
- [Whitepapers](https://www.pharmexec.com/whitepapers)

## Featured Content

- [Uncertainty Surrounding Pharma Tariff Deadlines](https://www.pharmexec.com/view/uncertainty-surrounding-tariff-deadlines): Troutman Pepper Locke senior associate Ryan Last explains when markets will start to significantly react to the upcoming pharma tariffs.
- [Realistic Timelines for Pharma Manufacturing Reshoring](https://www.pharmexec.com/view/realistic-timelines-manufacturing-reshoring): Ryan Last, senior associate at Troutman Pepper Locke explains how existing regulations and potential foreign countermeasures have a significant impact...
- [Pharmaceutical Executive Daily: The Medicare GLP-1 Bridge](https://www.pharmexec.com/view/daily-the-medicare-glp-1-bridge): In today's Pharmaceutical Executive Daily, AlzeCure Pharma announces a collaboration with QuantumCell ApS worth more than $2.2 billion for global righ...
- [Wegovy Now Available to Eligible Medicare Beneficiaries Through Medicare GLP-1 Bridge ](https://www.pharmexec.com/view/wegovy-available-eligible-medicare-beneficiaries-medicare-glp-1-bridge): Novo Nordisk has launched the Medicare GLP-1 Bridge, making Wegovy available to eligible Medicare beneficiaries for $50 a month through the end of 202...
- [AlzeCure Pharma Enters $2.2 Billion Licensing and Collaboration Agreement with QuantumCell ApS](https://www.pharmexec.com/view/alzecure-pharma-enters-2-billion-licensing-collaboration-agreement-quantumcell-aps): AlzeCure Pharma has licensed its NeuroRestore platform and lead CNS candidate ACD856 to QuantumCell ApS, following positive Phase Ib safety and pharma...
- [Targeted Onshoring's Impact on Domestic Pharma Manufacturing](https://www.pharmexec.com/view/targeted-onshoring-impact-domestic-manufacturing): Troutman Pepper Locke senior associate Ryan Last explains how thin margins on certain product will impact the effectiveness of tariffs.
- [Pharmaceutical Executive Daily: FDA Names Seven Participants to Precheck Program](https://www.pharmexec.com/view/daily-fda-names-seven-participants-precheck-program): In today's Pharmaceutical Executive Daily, FDA selects seven companies for its new PreCheck Pilot Program, Kirsten Whipple examines how the concept of...
- [Preparing for the July 31 Pharma Tariff Deadline](https://www.pharmexec.com/view/preparing-july-31-tariff-deadline): Ryan Last, senior associate at Troutman Pepper Locke, details the key steps that pharma companies must make before the July 31st deadline hits.
- [U.S. House Committee Investigating Drugmakers Involved in China Drug Trials: Report ](https://www.pharmexec.com/view/us-house-committee-investigating-drugmakers-china-drug-trials-report): A U.S. House committee has launched national security investigations into Merck, AbbVie, Eli Lilly, Pfizer, and Bristol Myers Squibb over their clinic...
- [FDA Announces Seven Participants to PreCheck Pilot Program](https://www.pharmexec.com/view/fda-announces-seven-participants-precheck-pilot-program): FDA selected seven companies to participate in its new PreCheck Pilot Program, offering earlier regulatory engagement and expedited facility review to...

## Feeds and Indexes

- [RSS Feed](https://www.pharmexec.com/rss.xml): Latest articles in XML syndication format
- [Sitemap](https://www.pharmexec.com/sitemap.xml): Complete URL index for all published pages
- [News Sitemap](https://www.pharmexec.com/sitemap-news.xml): Recent articles optimized for news indexing
- [Authors Directory](https://www.pharmexec.com/authors): Browse all contributors and their published work